3 Healthcare & Biotech Stocks up over 36% past 10 days
Powered by HealthTechMovers.com
Below is a list of 3 Healthcare & Biotech Stocks up over 36% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
Northwest Biotherapeutics, NWBO
Summary: Northwest Biotherapeutics, Inc. is a biotechnology company focused on discovering, developing, and commercializing immunotherapy products that safely generate and enhance immune system responses to treat cancer.
Ticker | Company | Sector | Prev Close | *Recent Price | % Price Change Past 10 Days |
NWBO | Northwest Biotherapeutics | Healthcare & Biotech | $1.6250 | $1.88 | +70% |
Here are 3rd party ratings for NWBO:
|
What’s the sentiment on the street? Current ratings compiled by TipRanks.com)
|
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Better Therapeutics Inc. is a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases. Better Therapeutics Inc., formerly known as Mountain Crest Acquisition Corp II, is based in SAN FRANCISCO.
Ticker | Company | Sector | Prev Close | *Recent Price | % Price Change Past 10 Days |
BTTX | Mountain Crest Acquisition II | Healthcare & Biotech | $2.1700 | $2.83 | +63% |
Here are 3rd party ratings for BTTX:
|
What’s the sentiment on the street? Current ratings compiled by TipRanks.com)
|
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Pear Therapeutics Inc. is involved in developing and commercializing software-based medicines, called prescription digital therapeutics. The company's principal pipeline of products include reset(R), for the treatment of substance use disorder, reSET-O(R), for the treatment of opioid use disorder and Somryst(R) for the treatment of chronic insomnia. Pear Therapeutics Inc., formerly known as Thimble Point Acquisition Corp., is based in BOSTON.
Ticker | Company | Sector | Prev Close | *Recent Price | % Price Change Past 10 Days |
PEAR | Pear Therapeutics | Healthcare & Biotech | $6.23 | $6.59 | +36% |
Here are 3rd party ratings for PEAR:
|
What’s the sentiment on the street? Current ratings compiled by TipRanks.com)
|
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------